Chugai Applies For Expiration Date Extension On Stockpiled Tamiflu
This article was originally published in PharmAsia News
The Japanese importer of the flu drug Tamiflu, Chugai Pharma, has applied to the Ministry of Health, Labor and Welfare to extend the expiration date of the product, which is stockpiled by Japanese national and local governments, from the current five years to seven years. To prepare for a possible flu pandemic, the government and local authorities have invested ¥54.4 billion to stockpile Tamiflu. Under the current expiration date, some of that stockpile will expire in two years and have to be disposed of. (Click here for more-Japanese language)
You may also be interested in...
TOKYO - Chugai Pharmaceutical said April 22 its net income in the first quarter dropped by roughly 50 percent compared to the same period last year due to weak sales of its influenza vaccine Tamiflu (oseltamivir). However, the Tokyo-based company revised and lifted its profit outlook until the end of the year in part due to lower than expected drug repricing efforts by the government
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.